RHÖN-KLINIKUM Aktiengesellschaft

XTRA:RHK 주식 보고서

시가총액: €836.7m

RHÖN-KLINIKUM 관리

관리 기준 확인 4/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Tobias Kaltenbach

최고 경영자

€507.0k

총 보상

CEO 급여 비율98.6%
CEO 임기2yrs
CEO 소유권n/a
경영진 평균 재임 기간4.2yrs
이사회 평균 재임 기간4.3yrs

최근 관리 업데이트

Recent updates

RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't

Jun 26
RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't

RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly

Apr 25
RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Mar 02
RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Dec 19
Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

Jul 13
Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

Jun 15
There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Aug 11
Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Apr 01
Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

May 14
Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

CEO 보상 분석

Tobias Kaltenbach 의 보수는 RHÖN-KLINIKUM 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

€45m

Jun 30 2024n/an/a

€47m

Mar 31 2024n/an/a

€43m

Dec 31 2023€507k€500k

€39m

Sep 30 2023n/an/a

€32m

Jun 30 2023n/an/a

€26m

Mar 31 2023n/an/a

€30m

Dec 31 2022€547k€83k

€25m

보상 대 시장: Tobias 의 총 보상 ($USD 533.74K ) German 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 1.42M ).

보상과 수익: Tobias 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Tobias Kaltenbach (64 yo)

2yrs

테뉴어

€507,000

보상

Dr. Tobias Kaltenbach is Chief Executive Officer & Chairman of the Management Board at RHÖN-KLINIKUM Aktiengesellschaft from November 2022. Mr. Kaltenbach served as Chairman of Corporate Management at Askl...

리더십 팀

이름위치테뉴어보상소유권
Tobias Kaltenbach
CEO & Chairman of Management Board2yrs€507.00k데이터 없음
Stefan Stranz
CFO & Member of Management Board4.2yrs€543.00k데이터 없음
Gunther Weiß
COO & Member of Management Board6.5yrs€625.00k데이터 없음
Julian Schmitt
Head of Investor Relations & Treasuryno data데이터 없음데이터 없음
Eugen Münch
Chief Representative4.3yrs€219.00k데이터 없음

4.2yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: RHK 의 관리팀은 경험 ( 4.2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Irmtraut Gurkan
Member of Supervisory Board4.3yrs€43.00k데이터 없음
Peter Berghofer
Member of Supervisory Board14.4yrs€45.00k데이터 없음
Oliver Salomon
Member of Supervisory Board6.7yrs€34.00k데이터 없음
Christine Reißner
Member of Supervisory Board9.4yrs€33.00k데이터 없음
Hafid Rifi
Second Deputy Chairman of the Supervisory Board4.3yrs€69.00k데이터 없음
Jan Liersch
Chairman of Supervisory Board4.4yrs€102.00k데이터 없음
Peter Ducke
Member of Supervisory Board4.3yrs€39.00k데이터 없음
Regina Dickey
Member of Supervisory Board4.3yrs€45.00k데이터 없음
Thomas Pillukat
Member of Supervisory Board4.3yrs€37.00k데이터 없음
Julia Dannath-Schuh
Member of Supervisory Board4.4yrs€31.00k데이터 없음
Martin Mandewirth
Member of Supervisory Board4.3yrs€35.00k데이터 없음
Stefan Rohrhoff
First Deputy Chairman of the Supervisory Boardless than a year데이터 없음데이터 없음

4.3yrs

평균 재임 기간

경험이 풍부한 이사회: RHK 의 이사회는 경험(평균 재직 기간 4.3 년)으로 간주됩니다.